Rheological characterization of fibrin-carrageenan composite hydrogels for 3D extrusion printing
Abstract
Fibrin-carrageenan composite hydrogels (FCCHs) are novel biomaterials with potential applications as artificial muscle tissue scaffolds. Fibrin is a crucial component for blood clotting and wound healing, and carrageenan is known to promote cell growth and differentiation. Both fibrin and carrageenan's mechanical properties allow for flexibility and tunability of the mixtures' viscoelasticity. This study investigated these novel hydrogels' rheology, printability, and biocompatibility. The FCCHs were assessed for stability, frequency dependence, and strain response. Furthermore, the strand width and pore printability were also compared with the control commercial LAMININK samples from CELLINK. Finally, in vitro cytotoxicity of the samples was tested using the 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay with NIH/3T3 fibroblasts. Results showed that the FCCH behaved similarly to that of the commercial ink in both its viscoelastic and printability properties. These results suggest that FCCH is a viable biomaterial ink for 3D-printed artificial muscle scaffolds.